Immunotherapy

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

As spring begins, patients with tree, grass and weed allergies may have to cope with oral allergy syndrome, which arises from an allergic reaction to certain fresh or raw foods, including vegetables, fruits and nuts, a specialist said.

Diabetes is more common in historically redlined neighborhoods, and residents of those neighborhoods have higher exposure to adverse social factors like discrimination, poverty, decreased food access and unemployment, researchers said.

Healio has compiled March’s most-read news in asthma and allergy.

WASHINGTON — Treatment-emergent adverse events with epicutaneous immunotherapy for peanut allergy grew less frequent and severe over 5 years, according to a poster at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Hybrid closed-loop insulin delivery systems are more cost-effective for treating type 1 diabetes than immune therapies unless the effects of immune therapies are persistent over a lifetime after one course, according to a speaker.

Within the past 2 decades, multiple myeloma has shifted from a highly lethal diagnosis to a condition that will no longer shorten the lifespan for many patients.

Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.

Lillian L. Siu, MD, FAACR, has been elected American Association for Cancer Research president-elect for 2024-2025.

More than 20% of reported cases of adverse events following bispecific T-cell engager therapies involved a cardiovascular event, findings reported in Journal for ImmunoTherapy of Cancer showed.